DRKS00022437已完成不适用
Prevalence of Gaucher Disease in Hematological Routine Practice – from Thrombocytopenia to Diagnosis of Gaucher Disease (PRAGMATIC-Diagnosis) - PRAGMATIC
BAG onkologische Schwerpunktpraxis0 个研究点目标入组 222 人开始时间: 2020年7月30日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 222
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one(—)
- 性别
- All
入选标准
- •1. unexplained thrombocytopenia: Platelet count < 150x109/l at two independent measurements
- •2. with unexplained thrombocytopenia (one platelet count < 150x109/l) and at least one other abnormal hematological parameter (leukocyte < 4x109/l, known serum ferritin >ULN, male patients: Hb < 8 mmol/l (13 g/dl), female patients: Hb < 7.5 mmol/l (12 g/dl)
- •3. ITP and known splenomegaly (according DGHO guidelines)
排除标准
- •1. Patients under the age of 18
- •2. Patients receiving cytopenia inducing treatment (e.g. chemotherapy)
- •3. Patients unable to state informed consent for genetic testing
- •4. Patients with known other causalities for thrombocytopenia e.g. viral disease (HIV, Hepatitis C), severe liver disease, autoimmune disease
- •5. Patients with ITP without splenomegaly (according DGHO guidelines)
- •6. Patients with comedication with a high probability to lead to thrombocytopenia
研究者
相似试验
已完成
不适用
Genzyme Osteopenia/Osteoporosis StudyGaucher DiseaseNCT02785744NYU Langone Health76
Unknown
不适用
Thrombocytopathy in Gaucher Disease PatientsThrombocytopathyGaucher DiseaseNCT01344096Rabin Medical Center70
已完成
不适用
Auto-antibodies Prevalence and CD1 Role in Gaucher DiseaseGaucher DiseaseNCT02650219Hospital St. Joseph, Marseille, France60
已完成
不适用
The Effect of Gaucher Disease on Bone CellsGaucher disease1000533010005959NL-OMON34135Vrije Universiteit Medisch Centrum24
招募中
不适用
Disease registry for patients with Gaucher disease.An observational program for patients with Gaucher disease that was designed to track the natural history and outcomes of patients.CTRI/2018/03/012357Sanofi Synthelabo India Private Limited
